Cell and Gene Therapy Process Stream

Discover our single-use consumables and supporting single-use platform solutions for optimal fluid management and product protection during the cell and gene therapy processes: Clinical Start, Manufacturing Upstream, Manufacturing Downstream, Clinical Application.

Click on each CGT process to discover more:

CL I N I C A L A PP L I C A T I O N DOWNSTREAM PROCESS UPSTREAM PROCESS CLINICAL START

With the use of our technology, biopharmaceutical companies in the area of Cell and Gene Therapy (CGT) and Regenerative Medicine can minimize the risk of bio contamination, manipulation or product loss towards 0%. For cell and gene therapies, such as CAR-T, many small batches of either t-cells, buffer salts, primary cells or media are supplied and delivered between biopharmaceutical companies, biotech companies, CMOs, CDMOs, hospitals and other suppliers.

Furthermore, we offer a framework for ATMPs of preventive and protective measures for this standard that reach a new and unrivaled quality level. Our development features all strengths of single-use bags. Potential weaknesses and risks, like material deficiencies or sensitive outer shells, are 100% compensated by our developments.

We call our process CGT.STREAM.